About
Michael Hunkapiller joined Alloy in 2004 after 30-year career in bioscience research and executive management in the life science industry. He focuses on investments in life science research tools and instrumentation, as well as clinical diagnostics. Operating experience A renowned scientist, entrepreneur and life science industry executive, Mike brings a unique mix of experience to Alloy. He spent 21 years at Applied Biosystems (NASDAQ: LIFE), which he co-founded and helped grow from startup to almost $2 billion in annual revenues supplying instrument and reagent systems for life science research. At ABI, he held several positions, most recently president and general manager. He was also a founder of ABI's sister company Celera Genomics (NASDAQ: CRA) and senior vice president of Applera Corp. (their parent company). Prior to joining ABI, Mike was a senior research fellow in the Division of Biology at the California Institute of Technology. He has authored more than 100 scientific p
Position in the VCSift Database
- • 5 investors at Alloy Ventures are tracked.
- • 626 investors hold the General Partner role in VCSift. Michael Hunkapiller is one of them.
- • 931 investors are based in Palo Alto, California, United States.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Palo Alto, US
Contact Information
Find more investors like Michael
Search Investors